https://www.selleckchem.com/pr....oducts/4-hydroxytamo
Posttraumatic stress disorder (PTSD) is associated with higher risk of certain chronic diseases, including ovarian cancer, but underlying mechanisms remain unclear. Although prior work has linked menopausal hormone therapy (MHT) use with elevated ovarian cancer risk, little research considers PTSD to likelihood of MHT use. We examined whether PTSD was prospectively associated with greater likelihood of initiating MHT use over 26 years. Using data from the Nurses' Health Study II, with trauma and PTSD (symptom
Like
Comment
Share
